Annual Total Long Term Liabilities
$38.71 M
-$225.31 M-85.34%
December 31, 2023
Summary
- As of February 10, 2025, ACOR annual total long term liabilities is $38.71 million, with the most recent change of -$225.31 million (-85.34%) on December 31, 2023.
- During the last 3 years, ACOR annual total long term liabilities has fallen by -$218.76 million (-84.97%).
Performance
ACOR Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$43.41 M
+$4.70 M+12.15%
March 31, 2024
Summary
- As of February 10, 2025, ACOR quarterly total long term liabilities is $43.41 million, with the most recent change of +$4.70 million (+12.15%) on March 31, 2024.
- Over the past year, ACOR quarterly long term liabilities has dropped by -$219.80 million (-83.51%).
Performance
ACOR Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ACOR Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -85.3% | -83.5% |
| 3 y3 years | -85.0% | -82.3% |
| 5 y5 years | -92.9% | -92.4% |
ACOR Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -85.3% | at low | -84.3% | -10.8% |
| 5 y | 5-year | -90.4% | at low | -89.2% | -10.8% |
| alltime | all time | -92.9% | -79.1% | -92.5% | -55.0% |
Acorda Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $43.41 M(+12.1%) |
| Dec 2023 | $38.71 M(-85.3%) | $38.71 M(-85.2%) |
| Sep 2023 | - | $261.09 M(-2.0%) |
| Jun 2023 | - | $266.44 M(+1.2%) |
| Mar 2023 | - | $263.21 M(-0.3%) |
| Dec 2022 | $264.02 M(+5.5%) | $264.02 M(-4.2%) |
| Sep 2022 | - | $275.55 M(-0.6%) |
| Jun 2022 | - | $277.29 M(+10.7%) |
| Mar 2022 | - | $250.59 M(+0.1%) |
| Dec 2021 | $250.31 M(-2.8%) | $250.31 M(+7.3%) |
| Sep 2021 | - | $233.34 M(-0.0%) |
| Jun 2021 | - | $233.36 M(-4.6%) |
| Mar 2021 | - | $244.72 M(-5.0%) |
| Dec 2020 | $257.47 M(-36.0%) | $257.47 M(-0.3%) |
| Sep 2020 | - | $258.17 M(-13.7%) |
| Jun 2020 | - | $299.07 M(-20.6%) |
| Mar 2020 | - | $376.52 M(-6.5%) |
| Dec 2019 | $402.51 M(-26.5%) | $402.51 M(-20.5%) |
| Sep 2019 | - | $506.58 M(-9.3%) |
| Jun 2019 | - | $558.67 M(-2.0%) |
| Mar 2019 | - | $570.07 M(+4.1%) |
| Dec 2018 | $547.43 M(+2.5%) | $547.43 M(-5.1%) |
| Sep 2018 | - | $576.75 M(+10.3%) |
| Jun 2018 | - | $523.11 M(+0.6%) |
| Mar 2018 | - | $519.79 M(-2.7%) |
| Dec 2017 | $534.02 M(+0.7%) | $534.02 M(-3.8%) |
| Sep 2017 | - | $555.33 M(+3.7%) |
| Jun 2017 | - | $535.58 M(+2.1%) |
| Mar 2017 | - | $524.38 M(-1.1%) |
| Dec 2016 | $530.22 M(+26.9%) | $530.22 M(-0.6%) |
| Sep 2016 | - | $533.48 M(+0.9%) |
| Jun 2016 | - | $528.87 M(+25.1%) |
| Mar 2016 | - | $422.68 M(+1.2%) |
| Dec 2015 | $417.68 M(+1.8%) | $417.68 M(-3.3%) |
| Sep 2015 | - | $432.15 M(+0.8%) |
| Jun 2015 | - | $428.60 M(+0.2%) |
| Mar 2015 | - | $427.80 M(+4.2%) |
| Dec 2014 | $410.43 M | $410.43 M(+17.6%) |
| Sep 2014 | - | $348.93 M(+0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $348.33 M(+422.5%) |
| Mar 2014 | - | $66.66 M(-4.9%) |
| Dec 2013 | $70.13 M(-12.9%) | $70.13 M(-2.6%) |
| Sep 2013 | - | $72.00 M(-3.0%) |
| Jun 2013 | - | $74.25 M(-3.5%) |
| Mar 2013 | - | $76.92 M(-4.5%) |
| Dec 2012 | $80.54 M(-7.4%) | $80.54 M(-2.9%) |
| Sep 2012 | - | $82.95 M(-2.4%) |
| Jun 2012 | - | $84.97 M(+0.1%) |
| Mar 2012 | - | $84.90 M(-2.3%) |
| Dec 2011 | $86.94 M(-10.0%) | $86.94 M(-3.1%) |
| Sep 2011 | - | $89.75 M(-1.1%) |
| Jun 2011 | - | $90.77 M(-2.8%) |
| Mar 2011 | - | $93.34 M(-3.4%) |
| Dec 2010 | $96.59 M(-11.6%) | $96.59 M(-3.0%) |
| Sep 2010 | - | $99.61 M(-2.8%) |
| Jun 2010 | - | $102.52 M(-2.9%) |
| Mar 2010 | - | $105.61 M(-3.3%) |
| Dec 2009 | $109.24 M(+453.4%) | $109.24 M(-6.2%) |
| Sep 2009 | - | $116.43 M(-4.7%) |
| Jun 2009 | - | $122.22 M(+525.4%) |
| Mar 2009 | - | $19.54 M(-1.0%) |
| Dec 2008 | $19.74 M(-19.8%) | $19.74 M(-21.6%) |
| Sep 2008 | - | $25.17 M(-1.9%) |
| Jun 2008 | - | $25.65 M(+5.8%) |
| Mar 2008 | - | $24.23 M(-1.5%) |
| Dec 2007 | $24.61 M(-8.1%) | $24.61 M(-2.3%) |
| Sep 2007 | - | $25.18 M(+0.7%) |
| Jun 2007 | - | $25.00 M(-2.8%) |
| Mar 2007 | - | $25.72 M(-4.0%) |
| Dec 2006 | $26.79 M(-76.6%) | $26.79 M(+26.0%) |
| Sep 2006 | - | $21.27 M(-5.2%) |
| Jun 2006 | - | $22.43 M(-3.7%) |
| Mar 2006 | - | $23.28 M(-79.7%) |
| Dec 2005 | $114.59 M(+51.4%) | $114.59 M(+17.4%) |
| Sep 2005 | - | $97.62 M(+198.5%) |
| Dec 2004 | $75.68 M(+835.4%) | - |
| Dec 2003 | $8.09 M(-69.7%) | - |
| Sep 2003 | - | $32.70 M |
| Jun 2003 | $26.71 M | - |
FAQ
- What is Acorda Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Acorda Therapeutics?
- What is Acorda Therapeutics annual total long term liabilities year-on-year change?
- What is Acorda Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Acorda Therapeutics?
- What is Acorda Therapeutics quarterly long term liabilities year-on-year change?
What is Acorda Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ACOR is $38.71 M
What is the all time high annual total long term liabilities for Acorda Therapeutics?
Acorda Therapeutics all-time high annual total long term liabilities is $547.43 M
What is Acorda Therapeutics annual total long term liabilities year-on-year change?
Over the past year, ACOR annual total long term liabilities has changed by -$225.31 M (-85.34%)
What is Acorda Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ACOR is $43.41 M
What is the all time high quarterly long term liabilities for Acorda Therapeutics?
Acorda Therapeutics all-time high quarterly total long term liabilities is $576.75 M
What is Acorda Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ACOR quarterly total long term liabilities has changed by -$219.80 M (-83.51%)